Metabolism
Serine/threonine kinase AMPK upregulates glucose uptake by promoting the expression and function of glucose transporters. AMPK is activated by increased AMP/ATP ratio, resulting from cellular and environmental stress, e.g. low glucose, heat shock, hypoxia and ischemia. AMPK activation positively modulates signaling transductions that refill ATP levels. Moreover, it also stimulates catabolic processes such as fatty acid oxidation and glycolysis through inhibition of ACC and activation of PFK2. AMPK negatively regulates various proteins which are important to ATP-consuming mechanisms, e.g. mTORC2, glycogen synthase, SREBP-1, and TSC2, causing the downregulation/inhibition of gluconeogenesis and glycogen, lipid and protein synthesis.
-
B5508 Alda 1Target: Aldehyde DehydrogenasesSummary: ALDH2 activator
-
B7794 BMS 3094032 CitationTarget: Fatty-acid-binding proteins (FABPs)Summary: FABP4 inhibitor,potent and selective
-
B4900 Indoximod (NLG-8189)Summary: Indoleamine 2,3-dioxygenase (IDO) pathway inhibitor
-
B4929 GSK 2837808ATarget: Lactate Dehydrogenases (LDH)Summary: Potent, selective lactate dehydrogenase A (LDHA) inhibitor
-
B6988 BRL 50481Target: Phosphodiesterases (PDEs)Summary: PDE7 inhibitor,potent and selective
-
B7417 Tunicamycin1 CitationSummary: antibiotic,inhibits GlcNAc phosphotransferase (GPT)
-
B5602 GGsTopSummary: γ-glutamyl transpeptidase (GGT) inhibitor, novel and irreversible
-
B6304 Etazolate hydrochloride2 CitationTarget: Phosphodiesterases (PDEs)Summary: PDE-4 inhibitor and selective GABA-A receptor modulator
-
B7010 15-deoxy-Δ-12,14-Prostaglandin J2Target: PPARSummary: PPARγ agonist